Literature DB >> 33649432

Treatment of pulmonary hypertension during initial hospitalization in a multicenter cohort of infants with congenital diaphragmatic hernia (CDH).

Ruth B Seabrook1, Theresa R Grover2, Natalie Rintoul3, Mark Weems4, Sarah Keene5, Beverly Brozanski6, Robert DiGeronimo7, Beth Haberman8, Holly Hedrick3, Jason Gien2, Noorjahan Ali9, Rachel Chapman10, John Daniel11, H Allen Harrison12, Yvette Johnson13, Nicolas F M Porta14, Michael Uhing15, Isabella Zaniletti16, Karna Murthy14.   

Abstract

OBJECTIVE: Describe inpatient pulmonary hypertension (PH) treatment and factors associated with therapy at discharge in a multicenter cohort of infants with CDH.
METHODS: Six years linked records from Children's Hospitals Neonatal Database and Pediatric Health Information System were used to describe associations between prenatal/perinatal factors, clinical outcomes, echocardiographic findings and PH medications (PHM), during hospitalization and at discharge.
RESULTS: Of 1106 CDH infants from 23 centers, 62.8% of infants received PHM, and 11.6% of survivors were discharged on PHM. Survivors discharged on PHM more frequently had intrathoracic liver, small for gestational age, and low 5 min APGARs compared with those discharged without PHM (p < 0.0001). Nearly one-third of infants discharged without PHM had PH on last inpatient echo.
CONCLUSIONS: PH medication use is common in CDH. Identification of infants at risk for persistent PH may impact ongoing management. Post-discharge follow-up of all CDH infants with echocardiographic evidence of PH is warranted.

Entities:  

Year:  2021        PMID: 33649432     DOI: 10.1038/s41372-021-00923-z

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  35 in total

1.  A clinical prediction rule for the severity of congenital diaphragmatic hernias in newborns.

Authors:  Mary Elizabeth Brindle; Earl Francis Cook; Dick Tibboel; Pamela A Lally; Kevin P Lally
Journal:  Pediatrics       Date:  2014-07-14       Impact factor: 7.124

2.  Congenital diaphragmatic hernia: treatment and outcomes.

Authors:  Andrea Badillo; Cynthia Gingalewski
Journal:  Semin Perinatol       Date:  2014-03       Impact factor: 3.300

Review 3.  Congenital diaphragmatic hernia - the past 25 (or so) years.

Authors:  Kevin P Lally
Journal:  J Pediatr Surg       Date:  2016-02-11       Impact factor: 2.545

Review 4.  Pulmonary vascular development in congenital diaphragmatic hernia.

Authors:  Daphne S Mous; Heleen M Kool; Rene Wijnen; Dick Tibboel; Robbert J Rottier
Journal:  Eur Respir Rev       Date:  2018-01-24

5.  Persistence of pulmonary hypertension by echocardiography predicts short-term outcomes in congenital diaphragmatic hernia.

Authors:  Leslie A Lusk; Katherine C Wai; Anita J Moon-Grady; Martina A Steurer; Roberta L Keller
Journal:  J Pediatr       Date:  2014-11-18       Impact factor: 4.406

6.  Prenatal prediction of survival in congenital diaphragmatic hernia: An audit of postnatal outcomes.

Authors:  Robin T Petroze; Natasha G Caminsky; Josée Trebichavsky; Sarah Bouchard; Annie Le-Nguyen; Jean-Martin Laberge; Sherif Emil; Pramod S Puligandla
Journal:  J Pediatr Surg       Date:  2019-01-31       Impact factor: 2.545

Review 7.  Abnormal lung development in congenital diaphragmatic hernia.

Authors:  Dustin Ameis; Naghmeh Khoshgoo; Richard Keijzer
Journal:  Semin Pediatr Surg       Date:  2017-04-25       Impact factor: 2.754

8.  Outcomes of congenital diaphragmatic hernia in the modern era of management.

Authors:  Julia Wynn; Usha Krishnan; Gudrun Aspelund; Yuan Zhang; Jimmy Duong; Charles J H Stolar; Eunice Hahn; John Pietsch; Dai Chung; Donald Moore; Eric Austin; George Mychaliska; Robert Gajarski; Yen-Lim Foong; Erik Michelfelder; Douglas Potolka; Brian Bucher; Brad Warner; Mark Grady; Ken Azarow; Scott E Fletcher; Shelby Kutty; Jeff Delaney; Timothy Crombleholme; Erika Rosenzweig; Wendy Chung; Marc S Arkovitz
Journal:  J Pediatr       Date:  2013-01-30       Impact factor: 4.406

9.  The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia.

Authors:  Peter W Dillon; Robert E Cilley; David Mauger; Christopher Zachary; Andreas Meier
Journal:  J Pediatr Surg       Date:  2004-03       Impact factor: 2.545

10.  Targeted drugs for pulmonary arterial hypertension: a network meta-analysis of 32 randomized clinical trials.

Authors:  Xiao-Fei Gao; Jun-Jie Zhang; Xiao-Min Jiang; Zhen Ge; Zhi-Mei Wang; Bing Li; Wen-Xing Mao; Shao-Liang Chen
Journal:  Patient Prefer Adherence       Date:  2017-05-08       Impact factor: 2.711

View more
  2 in total

Review 1.  The Cellular and Molecular Effects of Fetoscopic Endoluminal Tracheal Occlusion in Congenital Diaphragmatic Hernia.

Authors:  Oluyinka O Olutoye Ii; Walker D Short; Jamie Gilley; J D Hammond Ii; Michael A Belfort; Timothy C Lee; Alice King; Jimmy Espinoza; Luc Joyeux; Krithika Lingappan; Jason P Gleghorn; Sundeep G Keswani
Journal:  Front Pediatr       Date:  2022-07-05       Impact factor: 3.569

Review 2.  The heart in congenital diaphragmatic hernia: Knowns, unknowns, and future priorities.

Authors:  Neil Patel; Anna C Massolo; Ulrike S Kraemer; Florian Kipfmueller
Journal:  Front Pediatr       Date:  2022-08-16       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.